Literature DB >> 7716702

Mechanisms of genetic control of murine systemic lupus erythematosus.

S Izui1, R Merino, M Iwamoto, L Fossati.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7716702     DOI： 10.1007/bf00197514

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN： 0344-4325


× No keyword cloud information.
  123 in total

1.  Tumour necrosis factor and lymphotoxin genes map close to H-2D in the mouse major histocompatibility complex.

Authors:  U Müller; C V Jongeneel; S A Nedospasov; K F Lindahl; M Steinmetz
Journal:  Nature       Date:  1987 Jan 15-21       Impact factor: 49.962

2.  The proliferating cells in autoimmune MRL/lpr mice lack L3T4, an antigen on "helper" T cells that is involved in the response to class II major histocompatibility antigens.

Authors:  D Wofsy; R R Hardy; W E Seaman
Journal:  J Immunol       Date:  1984-06       Impact factor: 5.422

3.  Differential effect of the autoimmune Yaa and lpr genes on the acceleration of lupus-like syndrome in MRL/MpJ mice.

Authors:  R Merino; T Shibata; S De Kossodo; S Izui
Journal:  Eur J Immunol       Date:  1989-11       Impact factor: 5.532

4.  Induction of different types of glomerulonephritis by monoclonal antibodies derived from an MRL/lpr lupus mouse.

Authors:  J Itoh; M Nose; S Takahashi; M Ono; S Terasaki; E Kondoh; M Kyogoku
Journal:  Am J Pathol       Date:  1993-11       Impact factor: 4.307

5.  Immunoglobulin heavy chain constant region determines the pathogenicity and the antigen-binding activity of rheumatoid factor.

Authors:  T Fulpius; F Spertini; L Reininger; S Izui
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

6.  bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death.

Authors:  L H Boise; M González-García; C E Postema; L Ding; T Lindsten; L A Turka; X Mao; G Nuñez; C B Thompson
Journal:  Cell       Date:  1993-08-27       Impact factor: 41.582

7.  Tolerance to a self-protein involves its immunodominant but does not involve its subdominant determinants.

Authors:  R Cibotti; J M Kanellopoulos; J P Cabaniols; O Halle-Panenko; K Kosmatopoulos; E Sercarz; P Kourilsky
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

8.  The bcl-2 gene product inhibits clonal deletion of self-reactive B lymphocytes in the periphery but not in the bone marrow.

Authors:  S Nisitani; T Tsubata; M Murakami; M Okamoto; T Honjo
Journal:  J Exp Med       Date:  1993-10-01       Impact factor: 14.307

9.  Determinant capture as a possible mechanism of protection afforded by major histocompatibility complex class II molecules in autoimmune disease.

Authors:  H Deng; R Apple; M Clare-Salzler; S Trembleau; D Mathis; L Adorini; E Sercarz
Journal:  J Exp Med       Date:  1993-11-01       Impact factor: 14.307

10.  Development of autoimmune disease in SCID mice populated with long-term "in vitro" proliferating (NZB x NZW)F1 pre-B cells.

Authors:  L Reininger; T Radaszkiewicz; M Kosco; F Melchers; A G Rolink
Journal:  J Exp Med       Date:  1992-11-01       Impact factor: 14.307
View more
  2 in total

1.  Chronic administration of dexamethasone results in Fc receptor up-regulation and inhibition of class I antigen expression on macrophages from MRL/lpr autoimmune mice.

Authors:  S H Zuckerman; G F Evans; N Bryan
Journal:  Clin Diagn Lab Immunol       Date:  1997-09

2.  Susceptibility of T cell receptor-alpha chain knock-out mice to ultraviolet B light and fluorouracil: a novel model for drug-induced cutaneous lupus erythematosus.

Authors:  T Yoshimasu; T Nishide; N Seo; A Hiroi; T Ohtani; K Uede; F Furukawa
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.